VEXAS: A review of current understandings and emerging treatment strategies
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a late-onset autoinflammatory disorder, typically affecting males, caused by somatic mutations in the X-linked gene UBA1 encoding the E1 ubiquitin-activating enzyme. These mutations result in defective ubiquitination and dy...
Saved in:
Main Authors: | Robert Holden, Yogeshraj Jeelal, Andrew McLean-Tooke, Kylan Pathmanathan, David Nolan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1644404/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
VEXAS syndrome in a Moroccan patient: the story of a two-year diagnostic lag
by: Abire Allaoui, et al.
Published: (2025-06-01) -
VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?
by: Aleksandra Sowa, et al.
Published: (2025-05-01) -
Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature
by: Alnahas Z, et al.
Published: (2025-07-01) -
VEXAS syndrome: on the threshold of changing perceptions of known diseases
by: B. D. Chaltsev, et al.
Published: (2023-12-01) -
Digital Track Map for the VEXA expert system
by: Adam Hlubuček
Published: (2022-05-01)